GHRH analogue peptide
CJC-1295 updates
Answer
1 change for CJC-1295 in the last 12 months. Latest: 2026-04-16.
| Date | Type | What changed | Source |
|---|---|---|---|
| 2026-04-16 | Action | Ohio Board of Pharmacy: board | Regulator Ohio Board of Pharmacy |
| 2025-07-02 | Recall | FDA recall, Class II: Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado). Lack of Assurance of Sterility | Regulator FDA enforcement reports |
| 2024-10-25 | Federal Register | Federal Register notice: Pharmacy Compounding Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Bulk Drug Substances Nominated | Regulator Federal Register |
| 2023-12-04 | Action | California Board of Pharmacy: board | Regulator California Board of Pharmacy |
| 2021-11-17 | Recall | FDA recall, Class II: Vita Pharmacy, LLC dba Talon Compounding Pharmacy. Lack of assurance of sterility | Regulator FDA enforcement reports |
| 2020-12-23 | Recall | FDA recall, Class II: Advanced Nutriceuticals, LLC. Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products in | Regulator FDA enforcement reports |
| 2020-01-22 | Recall | FDA recall, Class II: Assurance Infusion. Lack of sterility assurance. | Regulator FDA enforcement reports |
| 2005-12-20 | Trial | New trial registered: A Study to Evaluate CJC 1295 in HIV Patients With Visceral Obesity | Trial register ClinicalTrials.gov |
From ClinicalTrials.gov, EU CTIS, FDA labels, recalls, shortages and warning letters, the Federal Register, and regulators' published actions. Not medical advice.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.